Randomized double blind clinical trial evaluating the Ellagic acid effects on insulin resistance, oxidative stress and sex hormones levels in women with polycystic ovarian syndrome

Table 2 The comparison of the dietary intake at the baseline and the end of the study in patients with IBS

Variables		Mean ± SD Placebo(n = 28)	Mean ± SD Ellagic acid (n = 29)	P1
Energy(kcal)	Baseline	2089.95 ± 245.09	2043.57 ± 233.11	0.307
	End	2033.28 ± 237.18	2026.38 ± 292.2	0.413
	P2	0.506	0.367
Protein(gr)	Baseline	86.42 ± 14.27	84.54 ± 16.41	0.508
	End	82.33 ± 14.09	83.63 ± 16.22	0.419
	P2	0.59	0.546
Carbohydrate(gr)	Baseline	270 ± 55.2	265.52 ± 50.04	0.502
	End	263.14 ± 50.5	261.33 ± 48.13	0.58
	P2	0.584	0.603
Fat (gr)	Baseline	73.80 ± 15.71	71.48 ± 14.41	0.714
	End	72.37 ± 15	70.83 ± 14	0.683
	P2	0.633	0.61
Saturated fatty acids(gr)	Baseline	26.2 ± 8.11	25.67 ± 9.18	0.656
	End	25.32 ± 8.17	24.27 ± 7.03	0.529
	P2	0.57	0.546
Monounsaturated Fatty acid (gr)	Baseline	22.11 ± 4.77	22.13 ± 3.19	0.807
	End	21.3 ± 4.03	22.17 ± 3.55	0.59
	P2	0.63	0.74
Polyunsaturated Fatty acid (gr)	Baseline	24.28 ± 7.64	23.18 ± 3.11	0.421
	End	22.9 ± 4.07	22.27 ± 5.17	0.365
	P2	0.29	0.267
Fiber(gr)	Baseline	10.51 ± 2.2	11.09 ± 3.06	0.129
	End	10.67 ± 2.31	11.43 ± 2.25	0.167
	P2	0.419	0.51
Vitamin C (mg)	Baseline	71.19 ± 25.69	72.38 ± 15.66	0.758
	End	70.07 ± 24.16	72.29 ± 14.19	0.801
	P2	0.603	0.711
Vitamin E (IU)	Baseline	10.24 ± 1.89	9.95 ± 2.5	0.309
	End	10.53 ± 1.77	10.07 ± 2.27	0.22
	P2	0.32	0.294
Selenium (μg/day)	Baseline	119.08 ± 35.63	120.24 ± 37.18	0.86
	End	118.14 ± 38.01	120.18 ± 38.27	0.891
	P2	0.883	0.805

Data are expressed as means ± SD
P1: Comparison of the mean of dietary intake between the two groups of Ellagic acid and placebo (Independent samples t-test)
P2: Comparison of mean of dietary intake in each group at baseline and end of study (Paired samples t-test)

ISSN: 1757-2215